Search Result for : Global Regulations

By Ranjeet Mahtani & Sweta Rajan On the path to complete all responsibilities and release the requisite laws, regulations and rates ahead of the proposed transition date of July 1, 2017, the GST Council met on June 3, 2017. The key developments during the meeting were: A committee comprising revenue officers from Centre and States is to be set up to entertain complaints relating to anti-profiteering. GST rates of the items which were not placed across the agreed rate slabs (after the Council’s meetings on 18 and 19 May, 2017) were decided, including 3% GST on gold and gold jewellery, 0.25% on rough diamonds, 5% on packaged food items sold under registered trademarks, 18% on biscuits, 5% on footwear priced below Rs. 500/- ...

The growth estimate has been revised down from 10%-12% to 5% for the current fiscal due to increased regulatory actions faced by Indian drug makers The Dollar Business Bureau India Rating and Research has revised the pharma sectors outlook for FY17 to stable from positive and said it expects muted export revenue growth and stable domestic revenue growth during the year   Indian pharmaceuticals exports, embattled with increased global regulations and depreciation of emerging market currencies, are expected to grow at a modest pace of 5% during the financial year 2016-17, a report has said. The domestic pharmaceutical market is likely to sustain the recently gained momentum of 13%-15% growth rate. However, the market will remain exposed to any expansion of the price control ...